Advanced search
Start date
Betweenand


Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?

Full text
Author(s):
Goncalves Zorzella-Pezavento, Sofia Fernanda ; Nishiyama Mimura, Luiza Ayumi ; Denadai, Marina Bonifacio ; Fernandes de Souza, William Danilo ; De Campos Fraga-Silva, Thais Fernanda ; Sartori, Alexandrina
Total Authors: 6
Document type: Journal article
Source: NEURAL REGENERATION RESEARCH; v. 17, n. 9, p. 10-pg., 2022-09-01.
Abstract

Multiple sclerosis is an autoimmune treatable but not curable disease. There are a multiplicity of medications for multiple sclerosis therapy, including a class entitled disease-modifying drugs that are mainly indicated to reduce the number and severity of disease relapses. Not all patients respond well to these therapies, and minor to severe adverse effects have been reported. Vitamin D, called sunshine vitamin, is being studied as a possible light at the end of the tunnel. In this review, we recapitulated the similar immunopathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis, the immunomodulatory and neuroprotective potential of vitamin D and the state-of-art concerning its supplementation to multiple sclerosis patients. Finally, based on our and other groups' experimental findings, we analyzed the need to consider the relevance of the route and the different time-point administration aspects for a more rational indication of this vitamin to multiple sclerosis patients. (AU)

FAPESP's process: 13/26257-8 - Tolerogenic efficacy of the association MOG/vitamin D analog or MOG/rapamycin on experimental autoimmune encephalomyelitis
Grantee:Alexandrina Sartori
Support Opportunities: Regular Research Grants
FAPESP's process: 13/01604-7 - Tolerogenic efficacy of the association MOG/vitamin D analog or MOG/rapamycin on experimental autoimmune encephalomyelitis
Grantee:Sofia Fernanda Gonçalves Zorzella Pezavento
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 19/15980-7 - Therapeutic efficacy of the organic selenium /vitamin A association in a relapsing-remitting multiple sclerosis model
Grantee:Marina Bonifácio Denadai
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 15/06706-8 - Vitamin D, paricalcitol, glibenclamide and clofazimine: therapeutic and immunomodulatory potential in experimental autoimmune encephalomyelitis
Grantee:Luiza Ayumi Nishiyama Mimura
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 13/14353-2 - Effect of Candida albicans infection on experimental Autoimmune Encephalitis Development
Grantee:Thais Fernanda de Campos Fraga da Silva
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)